CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 51 filers reported holding CIDARA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $199,000 | -44.3% | 99,993 | -53.0% | 0.08% | -44.0% |
| Q2 2019 | $357,000 | -36.7% | 212,766 | 0.0% | 0.13% | -44.9% |
| Q1 2019 | $564,000 | +12.8% | 212,766 | 0.0% | 0.24% | -2.4% |
| Q4 2018 | $500,000 | -46.6% | 212,766 | 0.0% | 0.25% | -35.2% |
| Q3 2018 | $936,000 | -15.4% | 212,766 | 0.0% | 0.38% | -25.9% |
| Q2 2018 | $1,106,000 | +1089.2% | 212,766 | +819.8% | 0.52% | +1051.1% |
| Q1 2018 | $93,000 | -93.7% | 23,132 | -89.3% | 0.04% | -94.3% |
| Q4 2017 | $1,472,000 | -12.8% | 216,403 | +3.8% | 0.79% | -24.4% |
| Q3 2017 | $1,689,000 | +8.1% | 208,458 | 0.0% | 1.05% | -5.9% |
| Q2 2017 | $1,563,000 | -3.9% | 208,458 | 0.0% | 1.12% | -18.9% |
| Q1 2017 | $1,626,000 | -2.2% | 208,458 | +30.4% | 1.38% | -5.9% |
| Q4 2016 | $1,663,000 | – | 159,918 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |